Recruiting

Community Violence Intervention

Sponsor:

NYU Langone Health

Code:

NCT07494019

Conditions

Community-Centered Safety

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

This study will describe, estimate, and explore the effectiveness of community-centered safety models (CCSMs)-including co-response, alternative response, and community violence intervention modalities-implemented across U.S. municipalities to prevent community violence among youth and young adults (YYA). Specifically, the investigators will (1) describe CCSM implementation using implementation-science methods, (2) estimate CCSMs' impacts on community-violence outcomes using quasi-experimental methods, and (3) explore operational and contextual factors associated with stronger or weaker effects.

Conditions

Community-Centered Safety

Study ID

NCT07494019

Start date

Sep 30, 2025

Status verified date

Mar, 2026

Completion date

Sep 29, 2028

Anticipated

Primary completion date

Sep 29, 2028

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria for Jurisdiction/Sites:

1. Intervention modality clarity: A single, identifiable CCSM-Co-Response (CRM), Alternative Response (ARM), or Community Violence Intervention (CVI)-implemented at city/county level.
2. Documented launch date \& scope: Public or official documentation specifying program start date, catchment, operating hours, staffing, eligibility, and core activities.
3. Observation window: ≥24 months pre-implementation and ≥12 months post-implementation of outcome data (monthly preferred; annual acceptable for fatal outcomes).
4. Outcomes coverage: Availability of primary outcomes (fatal and nonfatal violent injury) and at least one secondary justice outcome at the jurisdiction level.
5. Data quality: Stable geographic boundaries, consistent reporting practices, and no catastrophic breaks that preclude credible counterfactual fit.
6. Donor comparability: Jurisdiction characteristics and data cadence compatible with a pooled augmented synthetic control design (i.e., can be matched to a synthetic control and included in permutation tests).

Exclusion Criteria:

1. Pilot-only or indeterminate programs: Short-lived pilots, ambiguous or multi-modality rollouts where treatment timing or content cannot be reliably defined.
2. Severe data discontinuity: Major boundary changes, reporting suspensions, coding overhauls, or dataset gaps that undermine time-series integrity (e.g., prolonged outages during system migration) and cannot be addressed with standard remedies.
3. Overlapping major interventions: Concurrent, poorly measured citywide initiatives (e.g., sweeping policy bundles) that coincide with the CCSM start and make identification infeasible.
4. Insufficient pre-period: <24 months pre-implementation data for primary outcomes.
5. Incompatible cadence/aggregation: Outcomes only available at spatial or temporal units that cannot be aligned with other sites or donors.

Study Design

Enrollment

15 participants

Anticipated

Interventions and Outcome Measures

Arms

U.S. Cities/Counties

Approximately 15 U.S. cities/counties (≈5 per CCSM modality) selected for evaluability.

Primary outcome measure

  • Homicide Rate [ Time Frame: Baseline, Month 36 ]
  • Firearm Homicide Rate [ Time Frame: Baseline, Month 36 ]
  • Assault-related ED & inpatient encounters (combined) rate [ Time Frame: Baseline, Month 36 ]
  • Firearm-assault-related ED & inpatient encounters (combined) rate [ Time Frame: Baseline, Month 36 ]
  • Nonfatal firearm assault rate [ Time Frame: Baseline, Month 36 ]

Central Contacts and Locations

Locations

NYU Langone Health

Recruiting

New York, New York, United States, 10016

More Information

Sponsor

NYU Langone Health

Last update posted

Mar 27, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2026-03-27.